Petros Pharmaceuticals Inc. (NASDAQ: PTPI)
$0.2695
+0.0125 ( +4.86% ) 323.6K
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
Market Data
Open
$0.2695
Previous close
$0.2570
Volume
323.6K
Market cap
$2.68M
Day range
$0.2540 - $0.2820
52 week range
$0.2208 - $2.2700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k/a | Quarterly Reports | 18 | May 31, 2024 |
10-q | Quarterly Reports | 79 | May 15, 2024 |
10-k | Annual reports | 106 | Apr 01, 2024 |
8-k | 8K-related | 14 | Mar 22, 2024 |
8-k | 8K-related | 13 | Jan 12, 2024 |
8-k | 8K-related | 12 | Dec 29, 2023 |
8-k | 8K-related | 12 | Dec 28, 2023 |
4 | Insider transactions | 1 | Dec 26, 2023 |
4 | Insider transactions | 1 | Dec 26, 2023 |
4 | Insider transactions | 1 | Dec 26, 2023 |